Zhejiang Medicine Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Medicine Co., Ltd. with three other
companies in this sector in China:
Guizhou Xinbang Pharmaceutical Company Limited
(2016
sales of 5.16 billion Chinese Renmimbi [US$818.91 million]
of which 59%
was Pharmaceutical industry),
KPC Pharmaceuticals Inc
(5.10 billion Chinese Renmimbi [US$810.13 million]
of which 47%
was Drugs Wholesale and Retail), and
China Medical System Holdings Limited
(4.90 billion Chinese Renmimbi [US$778.40 million]
of which 100%
was Pharmaceutical Products).
Sales Analysis.
Zhejiang Medicine Co., Ltd. reported sales of 5.28 billion Chinese Renmimbi (US$838.43 million)
for the
year ending
December of 2016.
This
represents
an
increase of 17.4%
versus 2015, when the company's sales were 4.50 billion Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Zhejiang Medicine Co., Ltd. had sales
of 4.83 billion Chinese Renmimbi.
Sales of Other saw an increase
of
14.0% in 2016, from
8.08 million Chinese Renmimbi to 9.21 million Chinese Renmimbi.